Î²-cell neogenesis in streptozo- tocin -treated newborn rats resulting in persistently improved glucose homeosta-sis at adult age. Diabetes.  2001; 50:1562- 70. 18. Rayner CK, Samsom M, Jones KL et al. Relationships of upper gastrointestinalmotor and sensory function with glyce-mic control. Diabetes Care.  2001; 24:371- 81. 19. Greig NH, Holloway HW, De Ore KA et al. Once daily injection of exendin-4 todiabetic mice achieves long-term benefi-cial effects on blood glucose concentra-tions. Diabetologia.  1999; 42:45-50. 20. Goke R, Fehmann HC, Linn T et al. Exendin-4 is a high potency agonist andtruncated exendin-(9-39)-amide an antag-onist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secretingbeta-cells. J Biol Chem.  1993; 268: 19650- 5.21. World Medical Association declaration of Helsinski. Recommendations guidingphysicians in biomedical research involv-ing human subjects. JAMA.  1997; 277: 925-6. 22. Clements JA, Heading RC, Nimmo WS et